2016
DOI: 10.1073/pnas.1610242114
|View full text |Cite
|
Sign up to set email alerts
|

Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators

Abstract: Recurrent Pseudomonas aeruginosa infections coupled with robust, damaging neutrophilic inflammation characterize the chronic lung disease cystic fibrosis (CF). The proresolving lipid mediator, 15-epi lipoxin A4 (15-epi LXA4), plays a critical role in limiting neutrophil activation and tissue inflammation, thus promoting the return to tissue homeostasis. Here, we show that a secreted P. aeruginosa epoxide hydrolase, cystic fibrosis transmembrane conductance regulator inhibitory factor (Cif), can disrupt 15-epi … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
75
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 65 publications
(81 citation statements)
references
References 56 publications
4
75
0
Order By: Relevance
“…Furthermore, 14, 15-EET could stimulate the production of 15-epi LXA 4 [33], a dual anti-inflammatory and specialized pro-resolving mediator (SPM) that exert an essential role in inhibiting neutrophil activation and restoring homeostasis [13]. Although we did not observe the increase of lipoxins after cupping treatment for 24 hrs, 14, 15-EET significantly reduced IL-6 and TNF-α and in LPS-stimulated macrophages.…”
Section: Discussionmentioning
(Expert classified)
“…Furthermore, 14, 15-EET could stimulate the production of 15-epi LXA 4 [33], a dual anti-inflammatory and specialized pro-resolving mediator (SPM) that exert an essential role in inhibiting neutrophil activation and restoring homeostasis [13]. Although we did not observe the increase of lipoxins after cupping treatment for 24 hrs, 14, 15-EET significantly reduced IL-6 and TNF-α and in LPS-stimulated macrophages.…”
Section: Discussionmentioning
(Expert classified)
“…In addition to cSO, we also observed significant active-site side-chain shifts for another previously identified substrate, racemic cis -14(15)-epoxy-5Z,8Z,11Z-eicosatrienoic acid (14,15-EET, PDB ID: 5JYC) (Flitter et al, 2016). 14 R ,15 S -EET opens the active site to bulk solvent in two locations, creating a tunnel through the enzyme (Figure 6F).…”
Section: Resultsmentioning
confidence: 67%
“…Through a combination of X-ray structures and specific-activity measurements, we have outlined the substrate preferences for a bacterial epoxide hydrolase that sabotages human signaling networks (Flitter et al, 2016; MacEachran et al, 2007; Swiatecka-Urban, 2005). While the active site is constrained, it also exhibits a surprising degree of localized conformational flexibility that greatly expands the range of substrates it can accommodate.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The lungs of cystic fibrosis patients with recurrent Pseudomonas aeruginosa infection often represent a chronic hyper-inflammatory environment. Detailed lipid mediator analyses indicate that this pathogen secretes cystic fibrosis transmembrane conductance regulator inhibitory factor (Cif) which hydrolyzes 14,15-epoxyeicosatrienoic acid, thereby inhibiting the production of the proresolving lipid mediator 15-epi lipoxin A4 [38*]. …”
Section: Oxidative Lipidomics In Critical Illness and Related Pathophmentioning
confidence: 99%